Salivary concentration of epidermal growth factor in adults with reflux laryngitis before and after treatment

Annals of Otology, Rhinology and Laryngology

Volumn 122, Issue 7, 2013, Pages 440-444

  Eckley, Claudia A ^a   Sardinha, Luis Roberto ^a   Rizzo, Luiz Vicente ^a  

^a Assistant Prof Internal Medicine Dept Santa Casa School of Medicine and Hospitals of São Paulo   (Brazil)

Author keywords

Epidermal growth factor; Gastroesophageal reflux disease; GERD; Larynx; Saliva

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LARYNGITIS; LARYNGOPHARYNGEAL REFLUX; MALE; PRIORITY JOURNAL; REFLUX LARYNGITIS; SALIVA ANALYSIS; SALIVA LEVEL; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84881252295     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941312200705     Document Type: Article

References (34)

1. Vakil N, van Zanten S, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20, 1943.
2. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32-5.
3. Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extra- oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003;17:1515-20.
4. Erratum in Aliment Pharmacol Ther 2003;18:355
5. Richter JE. Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;22(suppl 1):70-80.
6. Groome M, Cotton JP, Borland M, McLeod S, Johnston DA, Dillon JF. Prevalence of laryngopharyngeal reflux in a population with gastroesophageal reflux. Laryngoscope 2007; 117:1424-8.
7. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009;104:1278-96.
8. Vaezi MF. Laryngeal manifestations of gastroesophageal reflux disease. Curr Gastroenterol Rep 2008;10:271-7.
9. Khan AM, Hashmi SR, Elahi F, Tariq M, Ingrams DR. Laryngopharyngeal reflux: a literature review. Surgeon 2006;4: 221-5.
10. Qua CS, Wong CH, Gopala K, Goh KL. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy. Aliment Pharmacol Ther 2007;25:287-95.
11. Gupta R, Sataloff RT. Laryngopharyngeal reflux: current concepts and questions. Curr Opin Otolaryngol Head Neck Surg 2009;17:143-8.
12. Dore MP, Pedroni A, Pes GM, et al. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Dig Dis Sci 2007;52:463-8.
13. Barry DW, Vaezi MF. Laryngopharyngeal reflux: more questions than answers. Cleve Clin J Med 2010;77:327-34.
14. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111:2147-51.
15. Mahieu HF. Review article: The laryngological manifestations of reflux disease; why the scepticism? Aliment Pharmacol Ther 2007;26(suppl 2):17-24.
16. Ali Mel-S. Laryngopharyngeal reflux: diagnosis and treatment of a controversial disease. Curr Opin Allergy Clin Immunol 2008;8:28-33.
17. Fass R. Distinct phenotypic presentations of gastroesophageal reflux disease: a new view of the natural history. Dig Dis 2004;22:100-7.
18. Navarro-Rodriguez T, Fass R. Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions - a debate: pro. Curr Treat Options Gastroenterol 2007;10:294-304.
19. Sonnenberg A, Steinkamp U, Weise A, et al. Salivary secretion in reflux esophagitis. Gastroenterology 1982;83:889-95.
20. Helm JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 1987;93:1393-7.
21. Jankowski J, Hopwood D, Wormsley KG. Expression of epidermal growth factor, transforming growth factor alpha and their receptor in gastro-oesophageal diseases. Dig Dis 1993;11: 1-11.
22. Olsen PS, Poulsen SS, Kirkegaard P, Nexø E. Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 1984;87:103-8.
23. Marcinkiewicz M, Han K, Zbroch T, et al. The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease. Am J Gastroenterol 2000;95:1652-60.
24. Rourk RM, Namiot Z, Sarosiek J, Yu Z, McCallum RW. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis. Am J Gastroenterol 1994;89: 237-44.
25. Sarosiek J, McCallum RW. Do salivary organic components play a protective role in health and disease of the esophageal mucosa? Digestion 1995;56(suppl 1):32-7.
26. Eckley CA, Michelsohn N, Rizzo LV, Tadokoro CE, Costa HO. Salivary epidermal growth factor concentration in adults with reflux laryngitis. Otolaryngol Head Neck Surg 2004;131:401-6.
27. [Erratum in Otolaryngol Head Neck Surg 2005;132:344.]
28. Eckley CA, Rios Lda S, Rizzo LV. Salivary egf concentration in adults with reflux chronic laryngitis before and after treatment: preliminary results. Braz J Otorhinolaryngol 2007; 73:156-60.
29. Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004;114:2129-34.
30. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313-7.
31. Belafsky PC, Postma GN, Koufmann JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274-7.
32. Postma GN, Belafsky PC, Aviv JE, Koufman JA. Laryngopharyngeal reflux testing. Ear Nose Throat J 2002;81(suppl 2):14-8.
33. Sato K, Umeno H, Chitose S, Nakashima T. Patterns of laryngopharyngeal and gastroesophageal reflux. J Laryngol Otol Suppl 2009 May;(31):42-7.
34. Itoh M, Joh T, Imai S, et al. Experimental and clinical studies on epidermal growth factor for gastric mucosal protection and healing of gastric ulcers. J Clin Gastroenterol 1988;10 (suppl 1):S7-S12.